Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours.

Saved in:
Bibliographic Details
Title: Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours.
Authors: Cheeseman SL; CRC Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK., Brannan M, McGown A, Khan P, Gardner C, Gumbrell L, Dickens D, Ranson M
Source: British journal of cancer [Br J Cancer] 2000 Dec; Vol. 83 (12), pp. 1599-606.
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Print ISSN: 0007-0920 (Print) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0007-0920
DOI:10.1054/bjoc.2000.1503